Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 731320Generated: October 30, 2026

Hydrochloric Acid → N-[3-[(4aR,7aS)-1-(3,3-dimethylbutyl)-4-hydroxy-2-oxo-5,6,7,7a-tetrahydro-4aH-cyclopenta[b]pyridin-3-yl]-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazin-7-yl]methanesulfonamide

https://huagongshe.com/reaction/731320

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
ReactantEthanolHCID 702—
Reactant4-MethylmorpholineHCID 7972—
ReactantSodium ethoxideHCID 2723922—
Reactant1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
Reactant2H-1,2,4-Benzothiadiazine-3-acetic acid, 7-[(methylsulfonyl)amino]-, 1,1-dioxideHCID 24858539—
Reactantcis-2-(3,3-Dimethylbutylamino)-cyclopentanecarboxylic acid ethyl esterHCID 57671253—
SolventDimethylformamideHCID 6228—
ProductN-[3-[(4aR,7aS)-1-(3,3-dimethylbutyl)-4-hydroxy-2-oxo-5,6,7,7a-tetrahydro-4aH-cyclopenta[b]pyridin-3-yl]-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazin-7-yl]methanesulfonamideHCID 13595571354.3%

Reaction Conditions

Temperature25 °C

Reaction Steps

(7-Methanesulfonylamino-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-acetic acid (prepared as described in Example 1j, 0.100 g, 0.300 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.060 g, 0.315 mmol) and N-methylmorpholine (0.070 mL, 0.630 mmol) were added sequentially to a solution of (1R,2S)-2-(3,3-dimethyl-butylamino)-cyclopentanecarboxylic acid ethyl ester (0.072 g, 0.300 mmol) in N,N-dimethylformamide (4 mL) at 25° C. The reaction mixture was stirred at 25° C. for 3 h, and then was partitioned between 1.0 M aqueous hydrochloric acid solution (110 mL) and ethyl acetate (2×110 mL). The organic layers were washed with saturated aqueous brine solution (100 mL), dried over sodium sulfate, filtered, and were concentrated in vacuo. The residue was dissolved in ethanol (4 mL) at 25° C. A 21% w/w solution of sodium ethoxide in ethanol (0.244 mL, 0.600 mmol) was added and the reaction mixture was heated to 60° C. for 2 h. After cooling to 25° C. and stirring for 16 h, the reaction mixture was slowly added to 1.0 M aqueous hydrochloric acid solution (50 mL) at 0° C. The resulting precipitate was collected by filtration and dried in vacuo, then was triturated with a small amount of methanol (ca. 0.5 mL) to afford the desired product, (4aR,7aS)-N-{3-[1-(3,3-dimethyl-butyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl]-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide (0.083 g, 0.163 mmol, 54%), as a white solid. 1H NMR (400 MHz, CDCl3) δ: 1.00 (s, 9H), 1.50-1.82 (m, 6H), 1.94-2.47 (m, 4H), 2.94-3.39 (m, 2H), 3.06 (s, 3H), 3.68-3.82 (m, 2H), 6.99 (bs, 1H), 7.21 (dd, 1H, J1=28.7 Hz, J2=8.4 Hz), 7.63 (t, 1H, J=8.9 Hz), 7.67-7.69 (m, 1H). LC-MS (ESI) calcd for C22H30N4O6S2 510.16, found 511.4 [M+H+].

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07582626B2
Source datasetuspto-grants-2009_09
ORD IDord-2f534f3e95d1433bb05ec11616442114
Source noteuspto-grants-2009_09